811
Views
7
CrossRef citations to date
0
Altmetric
Research Paper

Reconciling visual field defects and retinal nerve fibre layer asymmetric patterns in retrograde degeneration: an extended case series

, PhD DVM, , DPhil BOptom PGCertOcTher, , PhD BSc, , MOptom PGCertOcTher, , MBBS MBiomedE, , MBBS MBiomedE FRAZCO & , PhD MScOptom FAAO show all
Pages 214-226 | Received 14 Mar 2016, Accepted 01 Aug 2016, Published online: 15 Apr 2021

REFERENCES

  • Hayreh SS. Ischemic optic neuropathy. Prog Retin Eye Res 2009; 28: 34–62.
  • Park HY, Park YG, Cho AH et al. Trans‐neuronal retrograde degeneration of the retinal ganglion cells in patients with cerebral infarction. Ophthalmology 2013; 120: 1292–1299.
  • Pasol J. Neuro‐ophthalmic disease and optical coherence tomography: glaucoma look‐alikes. Curr Opin Ophthalmol 2011; 22: 124–132.
  • Huang‐link YM, Al‐hawasi A, Eveman I. Retrograde degeneration of visual pathway: hemimacular thinning of retinal ganglion cell layer in progressive and active multiple sclerosis. J Neurol 2014; 261: 2453–2456.
  • Jindahra P, Petrie A, Plant GT. The time course of retrograde trans‐synaptic degeneration following occipital lobe damage in humans. Brain 2012; 135: 534–541.
  • Klistorner A, Sriram P, Vootakuru N et al. Axonal loss of retinal neurons in multiple sclerosis associated with optic radiation lesions. Neurology 2014; 82: 2165–2172.
  • Danesh‐meyer HV, Boland MV, Savino PJ et al. Optic disc morphology in open‐angle glaucoma compared with anterior ischemic optic neuropathies. Invest Ophthalmol Vis Sci 2010; 51: 2003–2010.
  • Ambati BK, Rizzo JF 3rd. Non‐glaucomatous cupping of the optic disc. Int Ophthalmol Clin 2001; 41: 139–149.
  • Piette SD, Sergott RC. Pathological optic‐disc cupping. Curr Opin Ophthalmol 2006; 17: 1–6.
  • Zhang YX, Huang HB, Wei SH. Clinical characteristics of non‐glaucomatous optic disc cupping. Exp Therap Med 2014; 7: 995–999.
  • Prum BE Jr, Rosenberg LF, Gedded SJ et al. Primary Open-Angle Glaucoma Preferred Practice Pattern guidelines. Ophthalmology 2016; 123: P41–P111.
  • Wong E, Yoshioka N, Kalloniatis M et al. Cirrus HD‐OCT short‐term repeatability of clinical retinal nerve fiber layer measurements. Optom Vis Sci 2015; 92: 83–88.
  • Golnik K. Non‐glaucomatous optic atrophy. Neurol Clin 2010; 28: 631–640.
  • Xue K, Hildebrand GD. Retinal imaging: what the neurologist needs to know. Pract Neurol 2013; 13: 236–244.
  • Chiang J, Wong E, Whatham A et al. The usefulness of multimodal imaging for differentiating pseudopapilloedema and true swelling of the optic nerve head: a review and case series. Clin Exp Optom 2015; 98: 12–24.
  • Jamous KF, Kalloniatis M, Hayen A et al. Application of clinical techniques relevant for glaucoma assessment by optometrists: concordance with guidelines. Ophthalmic Physiol Opt 2014; 34: 580–591.
  • Simao LM. The contribution of optical coherence tomography in neurodegenerative diseases. Curr Opin Ophthalmol 2013; 24: 521–527.
  • Holmes G. The organizatin of the visual cortex in man. Proc Roy Soc Lond Ser B 1945; 132: 348–361.
  • Wong AM, Sharpe JA. Representation of the visual field in the human occipital cortex: a magnetic resonance imaging and perimetric correlation. Arch Ophthalmol 1999; 117: 208–217.
  • Ong YT, Hilal S, Cheung CY et al. Retinal neurodegeneration on optical coherence tomography and cerebral atrophy. Neurosci Lett 2015; 584: 12–16.
  • Sriram P, Graham SL, Wang C et al. Trans‐synaptic retinal degeneration in optic neuropathies: optical coherence tomography study. Invest Ophthalmol Vis Sci 2012; 53: 1271–1275.
  • Gabilondo I, Sepulveda M, Ortiz‐perez S et al. Retrograde retinal damage after acute optic tract lesion in MS. J Neurol Neurosurg Psychiatry 2013; 84: 824–826.
  • Trip SA, Schlottmann PG, Jones et al. Optic nerve atrophy and retinal nerve fibre layer thinning following optic neuritis: evidence that axonal loss is a substrate of MRI‐detected atrophy. NeuroImage 2006; 31: 286–293.
  • Savino PJ, Danesh‐meyer HV. Retrochiasmal disorders. In: Rapuano CJ ed. Color Atlas & Synopsis of Clinical Ophthalmology: Neuro‐Ophthalmology. Columbus, Ohio: McGraw‐Hill Companies, Inc, 2003. pp 132–141.
  • Jindahra P, Petrie A, Plant GT. Retrograde trans‐synaptic retinal ganglion cell loss identified by optical coherence tomography. Brain 2009; 132: 628–634.
  • Shon K, Sung KR. Assessment of macular ganglion cell loss patterns in neurologic lesions that mimic glaucoma. Korean J Ophthalmol 2014; 28: 314–322.
  • Kardon RH. Role of the macular optical coherence tomography scan in neuro‐ophthalmology. J Neuro‐ophthalmol 2011; 31: 353–361.
  • Keller J, Sanchez‐dalmau BF, Villoslada P. Lesions in the posterior visual pathway promote trans‐synaptic degeneration of retinal ganglion cells. PloS One 2014; 9: e97444.
  • Meier PG, Maeder P, Kardon RH et al. homonymous ganglion cell layer thinning after isolated occipital lesion: macular OCT demonstrates transsynaptic retrograde retinal degeneration. J Neuro‐ophthalmol 2015; 35: 112–116.
  • Foroozan R. Chiasmal syndromes. Curr Opin Ophthalmol 2003; 14: 325–331.
  • Fujimoto N, Saeki N, Miyauchi O et al. Criteria for early detection of temporal hemianopia in asymptomatic pituitary tumor. Eye 2002; 16: 731–738.
  • Monteiro ML, Zambon BK, Cunha LP. Predictive factors for the development of visual loss in patients with pituitary macroadenomas and for visual recovery after optic pathway decompression. Can J Ophthalmol 2010; 45: 404–408.
  • Danesh‐meyer HV, Wong A, Papchenko T et al. Optical coherence tomography predicts visual outcome for pituitary tumors. J Clin Neurosci 2015; 22: 1098–1104.
  • Monteiro ML, Medeiros FA, Ostroscki MR. Quantitative analysis of axonal loss in band atrophy of the optic nerve using scanning laser polarimetry. Br J Ophthalmol 2003; 87: 32–37.
  • Jamous KF, Kalloniatis M, Hennessy MP et al. Clinical model assisting with the collaborative care of glaucoma patients and suspects. Clin Exp Ophthalmol 2015; 43: 308–319.
  • Asaoka R, Russell RA, Malik R et al. A novel distribution of visual field test points to improve the correlation between structure‐function measurements. Invest Ophthalmol Vis Sci 2012; 53: 8396–8404.
  • Ferreras A, Pablo LE, Garway‐heath DF et al. Mapping standard automated perimetry to the peripapillary retinal nerve fiber layer in glaucoma. Invest Ophthalmol Vis Sci 2008; 49: 3018–3025.
  • Johnson H, Cowey A. Transneuronal retrograde degeneration of retinal ganglion cells following restricted lesions of striate cortex in the monkey. Exp Brain Res 2000; 132: 269–275.
  • Wong E, Yoshioka N, Kalloniatis M et al. Cirrus HD‐OCT short‐term repeatability of clinical retinal nerve fiber layer measurements. Optom Vis Sci 2015; 92: 83–88.
  • Heijl A, Buchholz P, Norrgren G et al. Rates of visual field progression in clinical glaucoma care. Acta Ophthalmol 2013; 91: 406–412.
  • Moon H, Yoon JY, Lim HT et al. Ganglion cell and inner plexiform layer thickness determined by spectral domain optical coherence tomography in patients with brain lesions. Br J Ophthalmol 2015; 99: 329–335.
  • Weinreb RN, Khaw PT. Primary open‐angle glaucoma. Lancet 2004; 363: 1711–1720.
  • Wang H, Wu LL, Song XY et al. Axonal transport of BDNF precursor in primary sensory neurons. European J Neurosci 2006; 24: 2444–2452.
  • Balk LJ, Twisk JW, Steenwijk MD et al. A dam for retrograde axonal degeneration in multiple sclerosis? J Neurol Neurosurg Psychiatry 2014; 85: 782–789.
  • You Y, Gupta VK, Li JC et al. Optic neuropathies: characteristic features and mechanisms of retinal ganglion cell loss. Rev Neurosci 2013; 24: 301–321.
  • American Academy of Ophthalmology. Basic and Clinical Science Course: Neuro‐Ophthalmology. Singapore, 2013–2014; section 5. San Francisco: American Academy of Ophthalmology, 2013.
  • Denniss J, Turpin A, Mckendrick AM. Individualized structure‐function mapping for glaucoma: practical constraints on map resolution for clinical and research applications. Invest Ophthalmol Vis Sci 2014; 55: 1985–1993.
  • Yoshioka N, Wong E, Kalloniatis et al. Influence of education and diagnostic modes on glaucoma assessment by optometrists. Ophthalmic Physiol Opt 2015; 35: 682–698.
  • Zangerl B, Hayen A, Mitchell P et al. Therapeutic endorsement enhances compliance with national glaucoma guidelines in Australian and New Zealand optometrists. Ophthalmic Physiol Opt 2015; 35: 212–224.
  • Biousse VR, Newman NJ. Neuro‐ophthalmology Illustrated. New York: Thieme, 2009.
  • Reeves AG. Disorders of the Nervous System: a Primer. Chicago, Illinois: Year Book Medical Publishers, 1981; Chapter 3.
  • Kennard C, Leigh J. Neuro‐Ophthalmology, Vol 102 (Handbook of Clinical Neurology). Available at: http://ezproxy.library.usyd.edu.au/login?url=http://www.sciencedirect.com/science/handbooks/00729752/129.